Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ewenstein

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 15, 2007
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitorsJ Teitel, E Berntorp, P Collins, et al.
Nature|November 20, 1986
Structure of pre-pro-von Willebrand factor and its expression in heterologous cellsD T Bonthron, R I Handin, R J Kaufman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2015
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia AR Kruse-Jarres, J St-Louis, A Greist, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statementE C Rodriguez-Merchan, A Rocino, B Ewenstein, et al.
Hamostaseologie|September 19, 2009
Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 15, 2007
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitorsJ Teitel, E Berntorp, P Collins, et al.
Nature|November 20, 1986
Structure of pre-pro-von Willebrand factor and its expression in heterologous cellsD T Bonthron, R I Handin, R J Kaufman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 28, 2015
Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia AR Kruse-Jarres, J St-Louis, A Greist, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 24, 2004
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statementE C Rodriguez-Merchan, A Rocino, B Ewenstein, et al.
Hamostaseologie|September 19, 2009
Development of a plasma- and albumin-free recombinant von Willebrand factorP L Turecek, A Mitterer, H P Matthiessen, et al.
Pageof 2